Bob Valamehr | Chief Research & Development Officer |
Scott Wolchko | Founder, President & Chief Executive Officer |
Ed Dulac | Chief Financial Officer |
Wayne Chu | Chief Medical Officer |
Michael Yee | Jefferies |
Yigal Nochomovitz | Citigroup |
Daina Graybosch | SVB Securities |
Nick Abbott | Wells Fargo |
Kelsey Goodwin | Guggenheim |
Mara Goldstein | Mizuho |
Robyn Karnauskas | Truist Securities |
Welcome to the Fate Therapeutics First Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode. This call is being webcasted live on Investors Section of Fate’s website at fatetherapeutics.com. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today’s call is being recorded.